Header Logo

Connection

CHRISTINA LYNN ROLAND to Humans

Back to Details
This is a "connection" page, showing publications CHRISTINA LYNN ROLAND has written about Humans.
CHRISTINA LYNN ROLAND
Connection Strength
0.961
Humans
  1. ASO Author Reflections: The Landmark Series: Multimodal Management of Oligometastatic Sarcoma. Ann Surg Oncol. 2024 Nov; 31(12):7967-7968.
    View in: PubMed
    Score: 0.019
  2. The Landmark Series: Multimodal Management of Oligometastatic Sarcoma. Ann Surg Oncol. 2024 Nov; 31(12):7930-7942.
    View in: PubMed
    Score: 0.019
  3. When to ditch the ladder and take the elevator: The Anderson SArcoma Risk of Complications (A-SARC) score to guide reconstructive decision-making in extremity soft tissue sarcoma patients. J Surg Oncol. 2024 Jun; 129(8):1456-1465.
    View in: PubMed
    Score: 0.018
  4. ASO Author Reflections: Is a Patient's Home Address Associated with Survival Outcomes After Surgery for Extremity and Truncal Soft Tissue Sarcoma? Ann Surg Oncol. 2024 Jun; 31(6):4148-4149.
    View in: PubMed
    Score: 0.018
  5. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma. Ann Surg Oncol. 2024 Jun; 31(6):4138-4147.
    View in: PubMed
    Score: 0.018
  6. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer. 2024 Apr; 5(4):625-641.
    View in: PubMed
    Score: 0.018
  7. Great Debate: Systematic Re-Resection After Macroscopic Complete Unplanned Excision of Soft Tissue Sarcoma. Ann Surg Oncol. 2024 03; 31(3):2047-2050.
    View in: PubMed
    Score: 0.018
  8. Is it possible to establish a calculable causal relationship between trauma and sporadic desmoid tumors? Cancer. 2024 01 01; 130(1):16-17.
    View in: PubMed
    Score: 0.018
  9. Maintaining Health-related Quality of Life for Desmoid Tumor Patients: The Proof is in the Data. Ann Surg. 2023 06 01; 277(6):884-885.
    View in: PubMed
    Score: 0.017
  10. ASO Author Reflections: A Call for Consensus, Collaboration and Data on the Role of Sentinel Lymph Node Biopsy for Soft Tissue Sarcoma. Ann Surg Oncol. 2023 02; 30(2):968-969.
    View in: PubMed
    Score: 0.017
  11. Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature. Ann Surg Oncol. 2023 Feb; 30(2):958-967.
    View in: PubMed
    Score: 0.017
  12. Optimizing Histology-Specific Clinical Trials in Soft-Tissue Sarcoma-Are We There Yet? JAMA Oncol. 2022 10 01; 8(10):1426-1427.
    View in: PubMed
    Score: 0.016
  13. Is quality related to quantity: Interpreting the results of STRASS in the context of noncompliant radiotherapy. Cancer. 2022 07 15; 128(14):2701-2703.
    View in: PubMed
    Score: 0.016
  14. Antibiotic Prophylaxis of Surgical Site Infections-A Double-edged Sword for Oncology Patients? JAMA Oncol. 2022 03 01; 8(3):340-342.
    View in: PubMed
    Score: 0.016
  15. Sailing to the Mediterranean and Navigating Amyotrophic Lateral Sclerosis. JAMA Neurol. 2021 08 01; 78(8):905-906.
    View in: PubMed
    Score: 0.015
  16. Impact of the COVID-19 Pandemic on Cancer Clinical Trials. Ann Surg Oncol. 2021 Nov; 28(12):7311-7316.
    View in: PubMed
    Score: 0.015
  17. ASO Author Reflections: Standardization in the Management of Retroperitoneal Sarcoma Through International Collaboration. Ann Surg Oncol. 2021 11; 28(12):7889-7890.
    View in: PubMed
    Score: 0.015
  18. National Utilization of Imatinib in the Management of Resected Gastrointestinal Stromal Tumors. Ann Surg Oncol. 2021 Dec; 28(13):9159-9168.
    View in: PubMed
    Score: 0.015
  19. ASO Author Reflections: Imatinib Use Remains Inadequate for High-Risk GIST Patients. Ann Surg Oncol. 2021 12; 28(13):9169-9170.
    View in: PubMed
    Score: 0.015
  20. What is the role of preoperative radiation in primary retroperitoneal sarcoma? Surgery. 2021 07; 170(1):318.
    View in: PubMed
    Score: 0.015
  21. ASO Author Reflections: Moving the Needle in Extremity and Trunk Soft Tissue Sarcoma. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):899-900.
    View in: PubMed
    Score: 0.014
  22. The Landmark Series: Multimodality Treatment of Extremity Sarcoma. Ann Surg Oncol. 2020 Oct; 27(10):3672-3682.
    View in: PubMed
    Score: 0.014
  23. Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum. Ann Surg Oncol. 2021 Jan; 28(1):570-575.
    View in: PubMed
    Score: 0.014
  24. ASO Author Reflections: Surveillance After Resection of Retroperitoneal Well-Differentiated Liposarcoma: A Balancing Act Between Earlier Recurrence Detection, Patient Anxiety, and Health Care Resource Expenditure. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):748-749.
    View in: PubMed
    Score: 0.014
  25. Soft Tissue Tumors of the Extremity. Surg Clin North Am. 2020 Jun; 100(3):669-680.
    View in: PubMed
    Score: 0.014
  26. Treatment for Advanced Soft Tissue Sarcoma: An Informative Neutral Trial. JAMA. 2020 04 07; 323(13):1251-1252.
    View in: PubMed
    Score: 0.014
  27. Clinical trials-Designing, implementing, and collaborating. J Surg Oncol. 2020 Jul; 122(1):25-28.
    View in: PubMed
    Score: 0.014
  28. An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter? Am J Clin Oncol. 2019 02; 42(2):160-165.
    View in: PubMed
    Score: 0.013
  29. Window-of-Opportunity Trials: The Road Forward in Soft Tissue Sarcoma and Beyond. Ann Surg Oncol. 2019 May; 26(5):1188-1189.
    View in: PubMed
    Score: 0.013
  30. ASO Author Reflections: Location-Specific Staging in Sarcoma-A Step in the Right Direction. Ann Surg Oncol. 2018 12; 25(Suppl 3):930-931.
    View in: PubMed
    Score: 0.012
  31. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer. 2018 12 01; 124(23):4495-4503.
    View in: PubMed
    Score: 0.012
  32. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018 Sep 24; 18(1):913.
    View in: PubMed
    Score: 0.012
  33. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities. Ann Surg Oncol. 2018 May; 25(5):1126-1132.
    View in: PubMed
    Score: 0.012
  34. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. J Surg Oncol. 2018 Apr; 117(5):879-885.
    View in: PubMed
    Score: 0.012
  35. The Hereditary Paraganglioma-Pheochromocytoma Syndrome: No Time to Waste-Reply. JAMA Oncol. 2017 12 01; 3(12):1740.
    View in: PubMed
    Score: 0.012
  36. Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol. 2018 01; 44(1):170-177.
    View in: PubMed
    Score: 0.012
  37. Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Oct; 24(11):3271-3278.
    View in: PubMed
    Score: 0.011
  38. Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection. Surgery. 2017 03; 161(3):753-759.
    View in: PubMed
    Score: 0.011
  39. Myxofibrosarcoma. Surg Oncol Clin N Am. 2016 10; 25(4):775-88.
    View in: PubMed
    Score: 0.011
  40. Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma. JAMA Surg. 2016 Apr; 151(4):347-54.
    View in: PubMed
    Score: 0.010
  41. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Ann Surg Oncol. 2016 07; 23(7):2220-8.
    View in: PubMed
    Score: 0.010
  42. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1221-8.
    View in: PubMed
    Score: 0.010
  43. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study. Melanoma Res. 2015 Aug; 25(4):335-41.
    View in: PubMed
    Score: 0.010
  44. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer. Ann Surg Oncol. 2015 Apr; 22(4):1168-75.
    View in: PubMed
    Score: 0.009
  45. Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res. 2014 Sep 15; 74(18):5301-10.
    View in: PubMed
    Score: 0.009
  46. Is timing to delivery of treatment a reliable measure of quality of care for patients with colorectal adenocarcinoma? Surgery. 2013 Sep; 154(3):421-8.
    View in: PubMed
    Score: 0.009
  47. A high positive lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinoma. J Gastrointest Surg. 2012 Nov; 16(11):2056-63.
    View in: PubMed
    Score: 0.008
  48. Routine nasogastric decompression is unnecessary after pancreatic resections. Arch Surg. 2012 Mar; 147(3):287-9.
    View in: PubMed
    Score: 0.008
  49. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. J Surg Oncol. 2012 May; 105(6):595-600.
    View in: PubMed
    Score: 0.008
  50. Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer. PLoS One. 2009 Nov 03; 4(11):e7669.
    View in: PubMed
    Score: 0.007
  51. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts. Mol Cancer Ther. 2009 Jul; 8(7):1761-71.
    View in: PubMed
    Score: 0.007
  52. Surgical approach and perioperative complications determine short-term outcomes in patients with insulinoma: results of a bi-institutional study. Ann Surg Oncol. 2008 Dec; 15(12):3532-7.
    View in: PubMed
    Score: 0.006
  53. ICAM-1 expression determines malignant potential of cancer. Surgery. 2007 Jun; 141(6):705-7.
    View in: PubMed
    Score: 0.006
  54. Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Mol Carcinog. 2025 Jan; 64(1):44-56.
    View in: PubMed
    Score: 0.005
  55. Diagnosis and management of dedifferentiated liposarcoma: A multidisciplinary position statement. Cancer Treat Rev. 2024 Dec; 131:102846.
    View in: PubMed
    Score: 0.005
  56. Patterns of Care and Outcomes of Patients with Small Gastrointestinal Stromal Tumors at a High-Volume Sarcoma Center. Ann Surg Oncol. 2024 Dec; 31(13):9258-9264.
    View in: PubMed
    Score: 0.005
  57. Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas): Single-Institution Study of 95 Surgical Patients. Ann Surg Oncol. 2024 Nov; 31(12):7950-7956.
    View in: PubMed
    Score: 0.005
  58. Current Management of Desmoid Tumors: A Review. JAMA Oncol. 2024 Aug 01; 10(8):1121-1128.
    View in: PubMed
    Score: 0.005
  59. Safety and Efficacy of Percutaneous Cryoablation for Recurrent or Metastatic Soft-Tissue Sarcoma in Adult Patients. AJR Am J Roentgenol. 2024 Oct; 223(4):e2431490.
    View in: PubMed
    Score: 0.005
  60. Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Mol Cancer Ther. 2024 Jul 02; 23(7):1057-1065.
    View in: PubMed
    Score: 0.005
  61. Optimizing Morbidity in Unplanned Soft Tissue Sarcoma Excisions: Should We Skip the Reconstructive Ladder? Ann Plast Surg. 2024 Sep 01; 93(3):361-368.
    View in: PubMed
    Score: 0.005
  62. Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver. Cancer. 2024 Aug 01; 130(15):2703-2712.
    View in: PubMed
    Score: 0.005
  63. Sarcoma Size and Limb Dimensions Predict Complications, Recurrence, and Death in Patients with Soft Tissue Sarcoma in the Thigh: A Multidimensional Analysis. Ann Surg Oncol. 2024 Aug; 31(8):5421-5430.
    View in: PubMed
    Score: 0.005
  64. Immuno-Oncology: New Insights into Targets and Therapies. Surg Oncol Clin N Am. 2024 Apr; 33(2):265-278.
    View in: PubMed
    Score: 0.004
  65. BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors. Cancer Gene Ther. 2024 Apr; 31(4):517-526.
    View in: PubMed
    Score: 0.004
  66. Identifying risk factors and analyzing reconstructive outcomes in patients with lower-extremity soft-tissue sarcoma. J Plast Reconstr Aesthet Surg. 2024 02; 89:174-185.
    View in: PubMed
    Score: 0.004
  67. SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection. Int J Radiat Oncol Biol Phys. 2024 Mar 15; 118(4):971-978.
    View in: PubMed
    Score: 0.004
  68. Data Dissemination of the Role of Neoadjuvant Radiation in Retroperitoneal Sarcoma: A CTOS and CSSO Survey. Curr Oncol. 2023 06 14; 30(6):5807-5815.
    View in: PubMed
    Score: 0.004
  69. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res. 2023 05 01; 29(9):1708-1718.
    View in: PubMed
    Score: 0.004
  70. The Landscape of Immunotherapy for Retroperitoneal Sarcoma. Curr Oncol. 2023 02 09; 30(2):2144-2158.
    View in: PubMed
    Score: 0.004
  71. ASO Author Reflections: Variability in Management of Sarcoma Lymph Node Metastases. Ann Surg Oncol. 2023 06; 30(6):3677-3678.
    View in: PubMed
    Score: 0.004
  72. Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. Ann Surg Oncol. 2023 Jun; 30(6):3668-3676.
    View in: PubMed
    Score: 0.004
  73. Reflections on the value of multidisciplinary oncology training by a medical oncologist. Eur J Surg Oncol. 2023 05; 49(5):1046-1047.
    View in: PubMed
    Score: 0.004
  74. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2022 12; 23(12):1547-1557.
    View in: PubMed
    Score: 0.004
  75. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med. 2023 02; 12(4):4282-4293.
    View in: PubMed
    Score: 0.004
  76. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. Ann Surg Oncol. 2023 Feb; 30(2):926-940.
    View in: PubMed
    Score: 0.004
  77. Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol. 2023 Jan; 30(1):480-489.
    View in: PubMed
    Score: 0.004
  78. ASO Author Reflections: Management of Patients with Soft Tissue Sarcoma Following Unplanned Excision. Ann Surg Oncol. 2023 01; 30(1):490-491.
    View in: PubMed
    Score: 0.004
  79. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol. 2022 09; 23(9):1156-1166.
    View in: PubMed
    Score: 0.004
  80. Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Ann Surg. 2023 08 01; 278(2):267-273.
    View in: PubMed
    Score: 0.004
  81. Relevant Trials Update in Sarcomas and Gastrointestinal Stromal Tumors: What Surgeons Should Know. Surg Oncol Clin N Am. 2022 07; 31(3):341-360.
    View in: PubMed
    Score: 0.004
  82. Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg Oncol. 2022 Nov; 29(12):7335-7348.
    View in: PubMed
    Score: 0.004
  83. Multidisciplinary Approach to Hemipelvectomy for Pelvic Sarcomas. JBJS Rev. 2022 05 01; 10(5).
    View in: PubMed
    Score: 0.004
  84. Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases. Ann Surg Oncol. 2022 Oct; 29(11):7092-7100.
    View in: PubMed
    Score: 0.004
  85. ASO Author Reflections: Lymph Node Disease in Soft Tissue Sarcoma: A Problematic Clinical Dilemma. Ann Surg Oncol. 2022 10; 29(11):7101.
    View in: PubMed
    Score: 0.004
  86. Adoption of Telemedicine for Postoperative Follow-Up After Inpatient Cancer-Related Surgery. JCO Oncol Pract. 2022 07; 18(7):e1091-e1099.
    View in: PubMed
    Score: 0.004
  87. Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center. Int J Cancer. 2022 06 15; 150(12):2012-2024.
    View in: PubMed
    Score: 0.004
  88. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol. 2021 09; 142(3):565-590.
    View in: PubMed
    Score: 0.004
  89. Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group. Ann Surg Oncol. 2021 Nov; 28(12):7873-7888.
    View in: PubMed
    Score: 0.004
  90. Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years. J Surg Oncol. 2021 Jul; 124(1):143-151.
    View in: PubMed
    Score: 0.004
  91. Desmoid Fibromatosis: Management in an Era of Increasing Options. Curr Oncol Rep. 2021 03 14; 23(4):41.
    View in: PubMed
    Score: 0.004
  92. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020. JAMA Netw Open. 2021 03 01; 4(3):e210945.
    View in: PubMed
    Score: 0.004
  93. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat. 2021 Apr; 186(3):871-882.
    View in: PubMed
    Score: 0.004
  94. Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers. Ann Surg Oncol. 2021 Sep; 28(9):4995-5004.
    View in: PubMed
    Score: 0.004
  95. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist. 2021 03; 26(3):250-260.
    View in: PubMed
    Score: 0.004
  96. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg. 2020 08; 272(2):e106-e111.
    View in: PubMed
    Score: 0.004
  97. Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies. Cancer. 2020 07 15; 126(14):3265-3273.
    View in: PubMed
    Score: 0.003
  98. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol. 2020 Sep; 34:182-185.
    View in: PubMed
    Score: 0.003
  99. Toxicity of Immune Checkpoint Inhibitors: Considerations for the Surgeon. Ann Surg Oncol. 2020 May; 27(5):1533-1545.
    View in: PubMed
    Score: 0.003
  100. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020 01; 577(7791):556-560.
    View in: PubMed
    Score: 0.003
  101. Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. Clin Cancer Res. 2020 03 15; 26(6):1258-1266.
    View in: PubMed
    Score: 0.003
  102. Management and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin. J Surg Oncol. 2020 Mar; 121(3):474-479.
    View in: PubMed
    Score: 0.003
  103. Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg. 2020 07; 220(1):140-146.
    View in: PubMed
    Score: 0.003
  104. Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control. Am J Clin Oncol. 2019 10; 42(10):744-748.
    View in: PubMed
    Score: 0.003
  105. The degree of sclerosis is associated with prognosis in well-differentiated liposarcoma of the retroperitoneum. J Surg Oncol. 2019 Sep; 120(3):382-388.
    View in: PubMed
    Score: 0.003
  106. Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery. Am J Clin Oncol. 2019 03; 42(3):238-242.
    View in: PubMed
    Score: 0.003
  107. Radiation and Its Impact on Local Recurrence in Extremity and Trunk Well-Differentiated Liposarcomas. Am Surg. 2019 Jan 01; 85(1):52-58.
    View in: PubMed
    Score: 0.003
  108. Long-Term Outcomes for Patients With Desmoid Fibromatosis Treated With Radiation Therapy: A 10-Year Update and Re-evaluation of the Role of Radiation Therapy for Younger Patients. Int J Radiat Oncol Biol Phys. 2019 04 01; 103(5):1167-1174.
    View in: PubMed
    Score: 0.003
  109. Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching. Gastric Cancer. 2018 11; 21(6):1004-1013.
    View in: PubMed
    Score: 0.003
  110. Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin. Cold Spring Harb Mol Case Stud. 2018 04; 4(2).
    View in: PubMed
    Score: 0.003
  111. Nongastrointestinal Stromal Tumor Spindle Cell Sarcomas of the Colon or Rectum. Am Surg. 2018 Apr 01; 84(4):570-575.
    View in: PubMed
    Score: 0.003
  112. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit. Ann Surg Oncol. 2018 Aug; 25(8):2193-2200.
    View in: PubMed
    Score: 0.003
  113. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. Cancer. 2018 03 01; 124(5):998-1007.
    View in: PubMed
    Score: 0.003
  114. Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center. J Surg Oncol. 2018 May; 117(6):1188-1194.
    View in: PubMed
    Score: 0.003
  115. Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases. Ann Surg Oncol. 2018 Jan; 25(1):107-116.
    View in: PubMed
    Score: 0.003
  116. Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery. J Surg Oncol. 2017 Sep; 116(3):313-319.
    View in: PubMed
    Score: 0.003
  117. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg. 2017 Jan; 126(1):319-329.
    View in: PubMed
    Score: 0.003
  118. Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates. J Surg Res. 2016 Jan; 200(1):158-63.
    View in: PubMed
    Score: 0.003
  119. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy. Histopathology. 2016 Jan; 68(2):210-20.
    View in: PubMed
    Score: 0.002
  120. Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. J Gastrointest Surg. 2015 Aug; 19(8):1476-83.
    View in: PubMed
    Score: 0.002
  121. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions. Ann Surg Oncol. 2015 Nov; 22(12):3913-20.
    View in: PubMed
    Score: 0.002
  122. Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Sci Rep. 2014 Mar 19; 4:4410.
    View in: PubMed
    Score: 0.002
  123. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol Cell. 2011 Feb 18; 41(4):458-70.
    View in: PubMed
    Score: 0.002
  124. r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction. PLoS One. 2010 Aug 06; 5(8):e12031.
    View in: PubMed
    Score: 0.002
  125. GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer. BMC Cancer. 2010 Jul 30; 10:397.
    View in: PubMed
    Score: 0.002
  126. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest. 2010 Jul; 120(7):2319-30.
    View in: PubMed
    Score: 0.002
  127. Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer. Cancer Res. 2010 Apr 01; 70(7):2852-61.
    View in: PubMed
    Score: 0.002
  128. The acellular fraction of stored platelets promotes tumor cell invasion. J Surg Res. 2009 May 01; 153(1):132-7.
    View in: PubMed
    Score: 0.002
  129. Prospective randomized control trial of intermittent versus continuous gastric feeds for critically ill trauma patients. J Trauma. 2007 Jul; 63(1):57-61.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.